BMS-986488
/ BMS
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 04, 2026
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=437 | Recruiting | Sponsor: Bristol-Myers Squibb | Active, not recruiting ➔ Recruiting
Enrollment open • Monotherapy • Colorectal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Pancreatic Ductal Adenocarcinoma • Renal Cell Carcinoma • Solid Tumor • KRAS
December 18, 2025
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=437 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Active, not recruiting
Enrollment closed • Monotherapy • Solid Tumor
April 04, 2025
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=437 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting
Enrollment open • Monotherapy • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1